Invesco’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $625K | Buy |
61,563
+21,144
| +52% | +$215K | ﹤0.01% | 3065 |
|
|
2025
Q1 | $226K | Buy |
40,419
+16,461
| +69% | +$91.9K | ﹤0.01% | 3449 |
|
|
2024
Q4 | $193K | Buy |
23,958
+1,876
| +8% | +$15.1K | ﹤0.01% | 3507 |
|
|
2024
Q3 | $226K | Sell |
22,082
-538
| -2% | -$5.51K | ﹤0.01% | 3474 |
|
|
2024
Q2 | $160K | Sell |
22,620
-471,548
| -95% | -$3.33M | ﹤0.01% | 3666 |
|
|
2024
Q1 | $6.79M | Buy |
494,168
+124,946
| +34% | +$1.72M | ﹤0.01% | 2043 |
|
|
2023
Q4 | $3.4M | Buy |
369,222
+27,685
| +8% | +$255K | ﹤0.01% | 2410 |
|
|
2023
Q3 | $2.07M | Sell |
341,537
-62,235
| -15% | -$377K | ﹤0.01% | 2577 |
|
|
2023
Q2 | $3.13M | Buy |
+403,772
| New | +$3.13M | ﹤0.01% | 2461 |
|
|
2022
Q2 | – | Sell |
-12,167
| Closed | -$65K | – | 4076 |
|
|
2022
Q1 | $65K | Buy |
12,167
+157
| +1% | +$839 | ﹤0.01% | 3868 |
|
|
2021
Q4 | $176K | Sell |
12,010
-1,516
| -11% | -$22.2K | ﹤0.01% | 3775 |
|
|
2021
Q3 | $282K | Buy |
13,526
+1,748
| +15% | +$36.4K | ﹤0.01% | 3640 |
|
|
2021
Q2 | $209K | Buy |
+11,778
| New | +$209K | ﹤0.01% | 3745 |
|